Clinical Decision Points for Two Plasma P-Tau217 Laboratory Developed Tests in Neuropathology Confirmed Samples
ALZHEIMER'S & DEMENTIA DIAGNOSIS, ASSESSMENT & DISEASE MONITORING（2025）
Key words
Alzheimer's disease,CSF A beta 42 to 40 ratio,CSF p-tau181,immunoassays,neuropathology diagnosis,plasma p-tau217
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined